Invited lecture slots still available until 6 April
More than 100 Invited Lecture slots are available for registrants that submit excellent new work
Deadline for Congress abstract submission:
6 April 2020
|
|
|
Looking for publication opportunities?
There will be three major opportunities to help you get your work published in leading international journals.
Publications workshop on Monday 29th June. Learn how to increase the chance that your research will be accepted for publication and why manuscripts are rejected.
Meet the Editors of the EFB Journal and other Elsevier journals who will answer your questions and provide advice.
Submit a publication to the Congress Special Issue. Participants are invited to submit research articles and reviews for a special issue of the EFB Journal, New Biotechnology, to be published after the Congress.
Register now to take advantage of these opportunities.
|
Special offer for group registrations from the same institution / organisation
Free registration is offered to Principal Scientists from large groups that register and pay together for five or more people from the same institution. Alternatively, one free registration - the least expensive - is offered to groups of four people from the same institution who register together and pay their registration fees with a single payment.
|
|
|
Save the dates and share your research with the global
SynBio community!
Early bird registration opening soon!
|
EFB Journal New Biotechnology
Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation
Antibody-cytokine fusion proteins represent a novel class of biopharmaceuticals, with the potential to increase the therapeutic index of cytokine ‘payloads’ and to promote leukocyte infiltration at the site of disease. In this review, we present a survey of immunocytokines that have been used in preclinical models of cancer and in clinical trials. In particular, we highlight how antibody format, choice of target antigen and cytokine engineering, as well as combination strategies, may have a profound impact on therapeutic performance. Moreover, by using anti-inflammatory cytokines, antibody fusion strategies can conveniently be employed for the treatment of auto-immune and chronic inflammatory conditions.
|
SCI Event
Applied late-stage functionalisation: where chemistry meets biology
The purpose of this meeting is to highlight some of the hot and emerging developments in the inorganic catalysis and biocatalysis arenas and both the academic and application of late-stage functionalisation methodologies.
This meeting is aimed at industrial and academic members of the scientific community working in pharmaceuticals, medicinal chemistry, biotechnology, chemical biology or broadly interested in synthesis, catalysis and enzymatic reactions.
|
|
Be in with the chance of winning a fantastic prize whilst supporting the global biosciences community: enter the Royal Society of Biology’s Anniversary Fundraising Raffle. All proceeds will go towards funding the RSB's charitable work and a full list of the exciting prizes can be found at www.rsb.org.uk/raffle. Enter by 25th February 2020.
|
EFB Member Events
BioTech 2020
co-organised by Czech Biotechnology Society
21 - 22 April 2020
London − UK
The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like EFB. ÖGMBT members are automatically members of these societies and are entitled many benefits such as 10% member discount for EFB organized congresses. Current calls and deadlines are published on our webpage and are sent to our members within the ÖGMBT newsletter.
Further info: https://www.oegmbt.at/ueber-uns/internationales
